Today: 22. Nov, 2024
In a recent update that has the biotech community buzzing, Iovance Biotherapeutics unveiled promising data at the 2024 American Society of Clinical Oncology (ASCO) meeting. This news not only reinforces the potential of their newly marketed cell therapy, Amtagvi, but also sets…
In the dynamic realm of pharmaceuticals, few companies boast a track record as impressive as Vertex Pharmaceuticals over the past ten years. Focused on addressing unmet medical needs, this biotech powerhouse has made significant strides, particularly in the treatment of cystic fibrosis…
Moderna announced on Wednesday its combined COVID and flu vaccine will proceed to the ultimate trial phase for adults aged 50 and above this year, following promising outcomes from preliminary to mid-phase research. To secure regulatory approval by 2025, Moderna’s mRNA-1083 shot…
